These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29146657)

  • 1. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
    Glaysher MA; Mohanaruban A; Prechtl CG; Goldstone AP; Miras AD; Lord J; Chhina N; Falaschetti E; Johnson NA; Al-Najim W; Smith C; Li JV; Patel M; Ahmed AR; Moore M; Poulter N; Bloom S; Darzi A; Le Roux C; Byrne JP; Teare JP
    BMJ Open; 2017 Nov; 7(11):e018598. PubMed ID: 29146657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity.
    Gersin KS; Keller JE; Stefanidis D; Simms CS; Abraham DD; Deal SE; Kuwada TS; Heniford BT
    Surg Innov; 2007 Dec; 14(4):275-8. PubMed ID: 18178916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes.
    Kral J; Benes M; Lanska V; Macinga P; Drastich P; Spicak J; Hucl T
    Obes Surg; 2024 May; 34(5):1407-1414. PubMed ID: 38436919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
    Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW
    Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids.
    Glaysher MA; Ward J; Aldhwayan M; Ruban A; Prechtl CG; Fisk HL; Chhina N; Al-Najim W; Smith C; Klimowska-Nassar N; Johnson N; Falaschetti E; Goldstone AP; Miras AD; Byrne JP; Calder PC; Teare JP
    Clin Nutr; 2021 Apr; 40(4):2343-2354. PubMed ID: 33131909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
    Patel SR; Hakim D; Mason J; Hakim N
    Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol.
    Murphy R; Evennett NJ; Clarke MG; Robinson SJ; Humphreys L; Jones B; Kim DD; Cutfield R; Plank LD; Hammodat H; Booth MW
    BMJ Open; 2016 Jul; 6(7):e011416. PubMed ID: 27377635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EndoBarrier for counteracting obesity and metabolic syndrome].
    Verdam FJ; Liedorp PR; Geubbels N; Schouten R; Janssen IM; Koek GH; Greve JW
    Ned Tijdschr Geneeskd; 2012; 156(13):A3844. PubMed ID: 22456287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Patel N; Mohanaruban A; Ashrafian H; Le Roux C; Byrne J; Mason J; Hopkins J; Kelly J; Teare J
    Obes Surg; 2018 Jul; 28(7):1980-1989. PubMed ID: 29450844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
    Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
    Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
    Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
    Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is reimplantation of the duodenal-jejunal bypass liner feasible?
    Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
    Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
    Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
    Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.
    Rohde U; Hedbäck N; Gluud LL; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Mar; 18(3):300-5. PubMed ID: 26537317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.
    Hollenbach M; Prettin C; Gundling F; Schepp W; Seufert J; Stein J; Rösch T; Aberle J; Feisthammel J; Petroff D; Hoffmeister A
    BMC Gastroenterol; 2018 Jul; 18(1):118. PubMed ID: 30021518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus.
    Seki Y; Kasama K; Umezawa A; Kurokawa Y
    Obes Surg; 2016 Sep; 26(9):2035-2044. PubMed ID: 26749411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
    Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
    Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.